New Clot-Busting devices aim to save limbs and lives
NCT ID NCT07350499
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing two catheter-based devices, Symphony and Prodigy, that remove blood clots from blood vessels in the legs, arms, or lungs. Researchers want to see if these devices can safely restore blood flow and prevent serious outcomes like amputation or heart strain. The trial will follow 750 adults for up to 30 days to check how well the devices work and if there are any complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Symphony and Prodigy thrombectomy systems (catheter-based devices that remove blood clots)
What this could lead to
If successful, these devices could offer a safer, more effective way to remove dangerous blood clots, potentially reducing the need for major surgery or long-term disability.
What could go wrong
This is an early-stage study with 750 participants, so results may not apply to everyone. There are risks of bleeding, vessel damage, or the device not fully clearing the clot.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BayCare Health - St. Joseph Hospital
RECRUITINGTampa, Florida, 33607, United States
-
Huntsville Hospital
RECRUITINGHuntsville, Alabama, 35801, United States
-
Mercy Health
RECRUITINGCincinnati, Ohio, 45242, United States
-
Profound Research
RECRUITINGMunster, Illinois, 46321, United States